Polyreactive Antibodies Developing Amidst Humoral Rejection of Human Kidney Grafts Bind Apoptotic Cells and Activate Complement
Fabrice Porcheray(Harvard University), Emmanuel Zorn(Columbia University Irving Medical Center), Timothy C. Girouard(Harvard University), Ynes Helou(Brown University), Robert B. Colvin(Harvard University), Augusto Vaglio(Meyer Children's Hospital), Ian Dargon(Massachusetts General Hospital), Susan L. Saidman(Harvard University), Umberto Maggiore(University of Parma), James W. Fraser(Harvard University), Wesley Wong(Columbia University), Baoshan Gao(Massachusetts General Hospital), R. Neal Smith(Beth Israel Deaconess Medical Center), Ann McColl(Harvard University), J. DeVito(Massachusetts General Hospital), Alessandra Palmisano(University of Parma)
Cited by 61
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k